SLS SELLAS LIFE SCIENCES GROUP INC Investor Conferences 8-K Filing 2023 - Virtual Panel Discussion on AML Treatment and GFH009 Potential SELLAS Life Sciences Group, Inc. hosted a virtual panel discussion on the treatment landscape for acute myeloid leukemia (AML) and the potential for GFH009 to address unmet medical needs for patients with relapsed and/or refractory AML.Get access to all SEC 8-K filings of the SELLAS LIFE SCIENCES GROUP INC